The NOURISH trial is addressing meals insecurity and malnutrition in sufferers present process therapy for his or her blood cancers.One of many many...
Liporaxel demonstrated non-inferiority in progression-free survival and superiority in general survival in comparison with intravenous paclitaxel as a second-line remedy for sufferers with...
Sufferers with BRAF V600E-mutant metastatic colorectal most cancers had poor scientific outcomes, with a median general survival of 17 months, no matter whether...
